跳至主要内容
临床试验/NCT03440541
NCT03440541已完成不适用

Uses of Gamma Irradiated Amniotic Membrane as an Alternative Method in Psoriasis Treatment

Egyptian Atomic Energy Authority2 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2015年8月4日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
22
试验地点
2
主要终点
Histopathological improvement

研究概览

简要总结

Using of human amniotic membrane extra-cellular matrix as a topical treatment for improving Psoriasis Area and Severity Index (PASI).

详细描述

Human amniotic membrane extra-cellular matrix was purchased from National center for radiation research and technology, Egypt, under commercial name REGE pro gel.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 40 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • patients have psoriasis lesion

排除标准

  • must stop other line of treatment

研究组 & 干预措施

treated

Experimental

Patients who received patches of REGE pro on psoriasis lesion weekly for 8 weeks

干预措施: REGE pro (Combination Product)

结局指标

主要结局

Histopathological improvement

时间窗: 6 weeks

Two biopsies were taken from each patient before and at the end of the treatment. It was noted that all histological signs as munro's microabscess and the elongation of rete ridges were absent.

Scaling size decrement

时间窗: 2 weeks

REGE pro gel decreased scaling size in patients with sever scales to moderate scale within two weeks, scaling size decrement from moderate to mild within two weeks, and from mild to complete curing within two weeks

次要结局

  • Erythema disappearing(4-6 weeks)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Nashwa Radwan

Director

Egyptian Atomic Energy Authority

研究点 (2)

Loading locations...

相似试验